IEFA Is a Great Choice for Most, but I Like VEA ETF Better
Investment
The Motley Fool

IEFA Is a Great Choice for Most, but I Like VEA ETF Better

June 28, 2025
04:05 PM
4 min read
AI Enhanced
stockstechnologyhealthcaremarket cyclesseasonal analysismarket

Key Takeaways

For investors in the United States, it's pretty easy to get overexposed to domestic stocks. These are the brands that you're most used to and the companies that you see...

Article Overview

Quick insights and key information

Reading Time

4 min read

Estimated completion

Category

investment

Article classification

Published

June 28, 2025

04:05 PM

Source

The Motley Fool

Original publisher

Key Topics
stockstechnologyhealthcaremarket cyclesseasonal analysismarket

For investors in the United States, it's pretty easy to get overexposed to domestic stocks

These are the brands that you're most used to and the companies that you see every day

It's easy to load up on what you know

Heck, even Warren Buffett makes that a central theme of his

But you shouldn't forget international exposure, and exchange-traded funds (ETFs) are some of the best ways to get there

ETFs give you exposure to hundreds or thousands of stocks with the click of a button

And that's why funds the is Core MSCI EAFE ETF (IEFA 0. 95%) are so

I actually think IEFA is a perfectly fine fund

But it's not my favorite for international exposure

There's a better option out there in the Vanguard FTSE Developed ETF (VEA 0. 62%) Let's take a look at these two funds

Image source: Getty Images

IEFA vides a strong starting point IEFA tracks the MSCI EAFE Investable Market Index, which is a market-cap weighted index that includes large-, mid-, and small-cap stocks from developed outside the U

And Canada. (EAFE stands for Europe, Australia and Asia, and the Far East. ) Because it also excludes emerging, you won't find any stocks from nations China, Brazil, or India

In total, IEFA includes 2,605 companies, with the top holdings including ASML, Nestle, Novo Nordisk, and AstraZeneca

The heaviest weighting in the fund is 1. 4%, so you know you're getting some serious diversification

So far this year, IEFA is up 15. 2%, which is better than the S&P 500's performance of 3

Its five-year performance is nearly 39%

With an expense ratio of 0. 07%, investors can expect to pay just $7 annually for each $10,000 they invest

Ly, IFEA is an excellent fund, and it's widely held for good reason

Why VEA is the better choice I'm not sure you could call IEFA vs

VEA an apples-to-oranges comparison

It's more comparing a good apple to one that's a little shinier

VEA tracks the FTSE Developed All Cap ex US Index

So it gives you access to small-, mid-, and large-cap stocks, in developed companies outside the U

But un IEFA, it also includes Canada and South Korea

That's why it tracks a whopping 3,839 companies, giving you even more diversification than IEFA

Top holdings also include ASML, Nestle, Novo Nordisk, and AstraZeneca

But you also find Toyota Motor in the top 10 of the VEA

No stock has a weighting of more than 1

VEA also gives you slightly better returns

It's up nearly 16% so far this year and 40% in the last five years

And you get an even lower expense ratio of 0. 03%, which means you're only paying $3 annually for each $10,000 you're

Metric IEFA VEA Expense ratio 0. 03% Year-to-date return 15. 9% Five-year return 38. 3% Equity holdings 2,605 3,839 Index tracked MSCI EAFE Investable Market Index FTSE Developed All Cap ex US Index Data source: Morningstar, author re

The bottom line There may be times when you want to invest in IEFA rather than VEA

For example, VEA might not be suitable if your portfolio already includes significant Canadian holdings, or is overweight in energy and natural resources, a sector where Canadian companies are minent

But in general, if you're looking for the efficient, affordable way to get international exposure from developed countries, VEA is the better choice

It's slightly cheaper, it offers more diversification, and it outperforms the IEFA

If you're building a set-it-and-forget-it portfolio, those little differences can add up in the long run

Patrick Sanders has no position in any of the stocks mentioned

The Motley Fool has positions in and recommends ASML and Vanguard Tax-Managed Funds - Vanguard Ftse Developed ETF

The Motley Fool recommends AstraZeneca Plc, Nestlé, and Novo Nordisk

The Motley Fool has a disclosure policy.